Salute e Benessere

Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis…

KOL Webinar: Seeking a Functional Cure for Chronic Hepatis BWednesday, September 20, 2023 between 14:00-15:00 ET. To register for the event, clickhere.The event will feature the following renowned thought leaders who will discuss the current treatment landscape for patients with HBV, combination approaches to enhancing rates of functional cure and the potential of antigen-specific immunotherapeutic approaches:Eleanor Barnes, MBBS, PhD, FRCP, FMedSci, Professor of Hepatology and...
Nasdaq GlobeNewswire
13/09/2023

Scivita Medical Single-use Broncho Videoscope Solution Showcased at ERS 2023

In the past, single-use videoscope is not able to provide high-resolution image. Scivita Medical Full HD Visualization Endoscopic Image Processor is all in one solution, proving digital video-out to display live image in high quality on external screen as well. It is applied both intensive care unit and operating room, including bedside bronchoscopy, intubation. airway examination, tracheotomy. bronchoscopy, and interventional surgery etc. In the past, single-use videoscope is not able to...
PR Newswire
13/09/2023

Pharmaceutical Grade Lithium Carbonate Market worth $166 million by 2028 -…

As the understanding of mental health conditions like bipolar disorder improves and more accurate diagnostic tools become available, there is expected to be an increased demand for medicines having pharmaceutical grade lithium carbonate that are used to manage these conditions. As the understanding of mental health conditions like bipolar disorder improves and more accurate diagnostic tools become available, there is expected to be an increased demand for medicines having pharmaceutical grade...
PR Newswire
13/09/2023

Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU…

COPENHAGEN, Denmark, September 13, 2023– Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded another contract valued at more than EUR 11 million to supply its MVA-BN ®smallpox vaccine to rescEU, a strategic reserve within the European Union (EU).This order follows an initial contract awarded in June 2023 and is also for delivery in 2024. The vaccines will be stockpiled in another EU country thus expanding the EU's capability to respond to biological threats and...
Nasdaq GlobeNewswire
13/09/2023

Microbiome Insights, Inc. Releases Updated Guide for Researchers Planning and…

The updated "How to Plan and Conduct a Microbiome Study" guide covers all essential microbiome research related topics, including study design considerations, sample collection and preservation techniques, DNA sequencing methodologies, cutting-edge bioinformatic analysis, and interpretation of results. It provides step-by-step guidance and practical insights to help researchers, whether they are experienced or new to microbiome research, enhance the quality and rigor of their…
PR Newswire
13/09/2023

J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of 'JIN-A02', a Novel…

This global phase 1/2 clinical study seeks to evaluate the safety, pharmacokinetics, and anti-tumor activity of "JIN-A02" in advanced NSCLC patients carrying EGFR mutations. This global phase 1/2 clinical study seeks to evaluate the safety, pharmacokinetics, and anti-tumor activity of "JIN-A02" in advanced NSCLC patients carrying EGFR mutations. This study is divided into three parts with dose escalation (Part A), dose exploration (Part B), and dose expansion (Part C). Part A…
PR Newswire
13/09/2023

Philips extends its mobile C-arm range with Zenition 30, alleviating staff…

Offering surgeons greater flexibility, control, and personalization in C-arm operation and image acquisition, Philips' new Zenition 30 reduces dependency on technician support for a wide variety of minimally invasive procedures Advanced imaging algorithms contribute to outstanding image quality and dose efficiency Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guided Therapy...
Nasdaq GlobeNewswire
13/09/2023

Medac GmbH Advances Pharmacovigilance Technology for Safety Monitoring of its…

"ArisGlobal's Safety solutions will significantly advance the automatization of adverse event management and intelligent safety analysis and will support us in making pharmacovigilance processes even smarter and more efficient," said Doctor Nadine Schreiber, Head of Global Pharmacovigilance of medac. "ArisGlobal's Safety solutions will significantly advance the automatization of adverse event management and intelligent safety analysis and will support us in making…
PR Newswire
13/09/2023

HERVOLUTION Therapeutics appoints Moderna Co-Founder and MIT Professor Robert S…

HERVs are well recognized as tumour specific antigens, but until now, have been undruggable. HERVOLUTION has overcome this challenge and developed a powerful technology that can stimulate both arms of the immune system, the humoral and cellular response, against this rogue antigen class. HERVs are well recognized as tumour specific antigens, but until now, have been undruggable. HERVOLUTION has overcome this challenge and developed a powerful technology that can stimulate both arms of the...
PR Newswire
13/09/2023

ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of…

ADCs prepared from bispecific antibodies are designed to overcome the limitations of conventional therapeutic ADCs that target only a single antigen on the targeted cancer cell. By designing ADCs that must bind to two different targets in order to produce a therapeutic effect, it is possible to target cancerous cells more specifically and further improve the therapeutic safety profile. ADCs prepared from bispecific antibodies are designed to overcome the limitations of conventional…
PR Newswire
13/09/2023

Neuroscience Center in Sweden Orders Nexstim NBS 5 System

Press release, Helsinki, 13 September 2023 at 10 AM(EEST) Neuroscience Center in Sweden Orders Nexstim NBS 5 System Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an NBS 5 system order from a new customer in Sweden.Nexstim's NBS (Navigated Brain Stimulation) System 5 is CE marked and FDA approved for presurgical mapping of the speech and motor cortices of the brain. In addition to its diagnostic capability, this specific system includes therapeutic...
Nasdaq GlobeNewswire
13/09/2023

Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a…

As the first domestically developed Class I anti-CD20 drug in China, Anruixi® will become BioRay's next major product following Anruize®. Additionally, clinical research is being conducted to explore the use of Anruixi® in the field of autoimmune diseases, such as primary immune thrombocytopenia (ITP). As the first domestically developed Class I anti-CD20 drug inChina, Anruixi® will become BioRay's next major product following Anruize®. Additionally, clinical research is being conducted to...
PR Newswire
13/09/2023

Novo Nordisk conducts a two-for-one stock split

Bagsværd, Denmark, 13 September 2023– As communicated on 10 August 2023 in connection with the release of Novo Nordisk's financial results for the first six months of 2023, Novo Nordisk's Board of Directors has approved a split of the trading units of the Novo Nordisk B shares listed on Nasdaq Copenhagen and of the American Depositary Receipts (ADRs) listed on New York Stock Exchange (NYSE) in a two-for-one ratio. Novo Nordisk's B shares have been listed on Nasdaq Copenhagen in trading...
Nasdaq GlobeNewswire
13/09/2023

The Global Digital Twins Market is expected to experience a significant growth…

The growing interest in digital twin market can be validated from the fact that, in the last two years, close to USD 6 billion has been invested by several investors based across the globe, in companies engaged in the development or those offering digital twins. Majority of the funds have been raised through venture rounds. In terms of the amount of funds raised, Babylon Health and Certara are the leading digital twin companies, essentially owing to their IPOs in 2021. Interestingly, the…
PR Newswire
13/09/2023

Menopause Market to Grow Rapidly at a CAGR of 1.2% by 2032, Predicts…

Key Takeaways from the Menopause Market Report Key Takeaways from the Menopause Market Report Discover which therapies are expected to grab the major menopause market share @Menopause Market Report Menopause Overview Menopause is a natural biological process that marks the end of a woman's reproductive years. It usually occurs between the ages of 45 and 55, with an average age of around 51. This phase is characterized by a decline in the production of hormones like estrogen...
PR Newswire
12/09/2023

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Nyxoah to Participate in theCantor Fitzgerald Global HealthcareConferenceMont-Saint-Guibert, Belgium – September12 , 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Cantor Fitzgerald Global Healthcare Conference, which...
Nasdaq GlobeNewswire
12/09/2023

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; September 12, 2023 –Genmab A/S (Nasdaq: GMAB) will increase its share capital by 10,356 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 830 shares at DKK 1,025.00, 644 shares at DKK 1,032.00, 500 shares at DKK 1,136.00, 4,658...
Nasdaq GlobeNewswire
12/09/2023

New Study Evaluates How Quickly the Migraine Preventive Impact of Nerivio®…

A previous study has already shown that using Nerivio every other day for 8 weeks reduces the mean number of migraine days per month by 4.0 days (compared to 1.3 days in the placebo group, p < 0.001). The study (NCT04828707) was a prospective, randomized, double-blind, placebo-controlled clinical trial that evaluated the efficacy of REN treatment applied every other day for the prevention of migraine. The trial included a 4-week baseline (observation) phase and an 8-week double-blind…
PR Newswire
12/09/2023

IBA - Regulated Information

Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions ( Belgian Gazette 12.VI.2007) (hereinafter, the “Law”) Under this provision: "[...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as well as, by category, the number of securities conferring the...
Nasdaq GlobeNewswire
12/09/2023

The opportunity within the Fill Finish Manufacturing of Biologics Market to grow…

The biopharmaceutical industry has witnessed substantial number of partnerships and collaborations between drug developers and fill/finish contract manufacturing organizations over the last few years. The COVID 19 pandemic also led to an increase in the demand for fill finish of vaccines, leading to a rise in the number of service agreements. For fulfilling the demand for its COVID vaccine in Europe, Pfizer and BioNTech collaborated with Delpharm, Thermo Fisher Scientific and more companies for…
PR Newswire
12/09/2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 36 - 2023

Aggregatedpresentationbydayandbymarket NameofissuerIdentificationcodeof issuer(Legal Entity Identifier)Day of transactionIdentificationcodeof financialinstrumentAggregated daily volume(innumber of shares)Dailyweightedaveragepriceof the purchased shares *Market(MICCode) IPSEN549300M6SGDPB4Z94P1104/09/2023FR001025915040116.99AQEUIPSEN549300M6SGDPB4Z94P1104/09/2023...
Nasdaq GlobeNewswire
12/09/2023

Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior…

Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025(ISIN: BE6325746855)Liege, Belgium ,12 September2023–5:45 pm CEST– Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the " Company " or " Mithra "), a company dedicated to Women's Health, confirms to Bondholders that, in accordance with the terms and conditions of the Company's EUR 125,000,000 senior unsecured convertible bonds due...
Nasdaq GlobeNewswire
12/09/2023

Veterinary Healthcare Top Trending Markets - By The Business Research Company

In this dynamic and evolving market, businesses can benefit greatly from the insights provided by reports from The Business Research Company (TBRC) in the veterinary healthcare industry. TBRC's reports offer a comprehensive analysis of market trends, competitive landscapes, and emerging opportunities. In this dynamic and evolving market, businesses can benefit greatly from the insights provided by reports from The Business Research Company (TBRC) in the veterinary healthcare industry...
PR Newswire
12/09/2023

Publication of a Transparency Notification Received from Armistice Capital…

Publication of a Transparency Notification Received from Armistice Capital, LLC Liege, Belgium ,12 September2023– 5:45pm CEST– Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it...
Nasdaq GlobeNewswire
12/09/2023
Altri  Comunicati